Using two distinct models of colitis - chemical dextran sulphate sodium (DSS)-induced injury, and a T-cell driven adoptive transfer model - we investigated the dichotomous effects of Gal-9 deficiency, as well as the impact of exogenous Gal-9 treatment. The gene discussed is LGALS9; the disease is colitis.